Literature DB >> 23831511

Protective effect of the KIR2DS1 gene in atopic dermatitis.

Wanda Niepiekło-Miniewska1, Edyta Majorczyk, Lukasz Matusiak, Ketevan Gendzekhadze, Izabela Nowak, Joanna Narbutt, Aleksandra Lesiak, Piotr Kuna, Joanna Ponińska, Aneta Pietkiewicz-Sworowska, Bolesław Samoliński, Rafał Płoski, Jacek C Szepietowski, David Senitzer, Piotr Kuśnierczyk.   

Abstract

Atopic dermatitis (AD) is a common skin disease of complex etiology including affected humoral and cellular immune responses. The role of NK cells in development of this disease has been recently postulated, but is still poorly documented. The current study was undertaken to determine the impact of genes for the most polymorphic NK cell receptors, known as killer cell immunoglobulin-like receptors (KIRs), on the development of AD. We compared 240 patients suffering from AD with 570 healthy controls. Frequencies of the great majority of KIR genes did not differ between patients and controls, except for KIR2DS1, whose frequency was significantly (OR=0.629, CI95% (0.45; 0.87), pcorr=0.0454) lower in patients than in controls. These results were confirmed in a second cohort of 201 patients. When both patient groups were combined and compared to the control group, the result for KIR2DS1 achieved even higher significance (OR=0.658, CI95% (0.5; 0.86), pcorr=0.0158). To the best of our knowledge, this is the first report on KIR gene contribution to AD, and to allergy in general.
© 2013.

Entities:  

Keywords:  95% confidence intervals; AD; Atopic dermatitis; CD; CI95%; DNA; Genetics; HLA; HLA-C; KIR; Killer cell immunoglobulin-like receptor; LD; OR; PCR-SSP; SCORAD; UV; atopic dermatitis; cluster of differentiation; corrected p; deoxyribonucleic acid; human leukocyte antigen; killer cell immunoglobulin-like receptor; linkage disequilibrium; odds ratio; p; p(corr); polymerase chain reaction using sequence-specific primers; probability; scoring atopic dermatitis, index of disease severity; ultraviolet

Mesh:

Substances:

Year:  2013        PMID: 23831511     DOI: 10.1016/j.gene.2013.06.015

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis.

Authors:  Madison R Mack; Jonathan R Brestoff; Melissa M Berrien-Elliott; Anna M Trier; Ting-Lin B Yang; Matthew McCullen; Patrick L Collins; Haixia Niu; Nancy D Bodet; Julia A Wagner; Eugene Park; Amy Z Xu; Fang Wang; Rebecca Chibnall; M Laurin Council; Carrie Heffington; Friederike Kreisel; David J Margolis; David Sheinbein; Paola Lovato; Eric Vivier; Marina Cella; Marco Colonna; Wayne M Yokoyama; Eugene M Oltz; Todd A Fehniger; Brian S Kim
Journal:  Sci Transl Med       Date:  2020-02-26       Impact factor: 17.956

Review 2.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

3.  Association of KIR Genes and MHC Class I Ligands with Atopic Dermatitis.

Authors:  David J Margolis; Nandita Mitra; Ole J Hoffstad; Brian S Kim; Dimitri S Monos; Elizabeth J Phillips
Journal:  J Immunol       Date:  2021-08-18       Impact factor: 5.426

4.  HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study.

Authors:  David J Margolis; Nandita Mitra; Brian S Kim; Jamie L Duke; Ron A Berna; Ole J Hoffstad; Jenna R Wasserman; Deborah A Ferriola; Tim L Mosbruger; Bradley S Wubbenhorst; Kathrine L Nathanson; Dimitri S Monos
Journal:  J Immunol       Date:  2021-04-16       Impact factor: 5.422

5.  Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis.

Authors:  Wanda Niepiekło-Miniewska; Łukasz Matusiak; Joanna Narbutt; Alekandra Lesiak; Piotr Kuna; Andrzej Wiśniewski; Piotr Kuśnierczyk
Journal:  Life (Basel)       Date:  2021-04-10

6.  Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-control study.

Authors:  D J Margolis; N Mitra; J L Duke; R Berna; J D Margolis; O Hoffstad; B S Kim; A C Yan; A L Zaenglein; Z Chiesa Fuxench; A Dinou; J Wasserman; N Tairis; T L Mosbruger; D Ferriola; Georgios Damianos; Ioanna Kotsopoulou; D S Monos
Journal:  Hum Immunol       Date:  2021-04-17       Impact factor: 2.211

Review 7.  Activating killer cell Ig-like receptors in health and disease.

Authors:  Martin A Ivarsson; Jakob Michaëlsson; Cyril Fauriat
Journal:  Front Immunol       Date:  2014-04-22       Impact factor: 7.561

8.  KIR2DS5 in the presence of HLA-C C2 protects against endometriosis.

Authors:  Izabela Nowak; Rafał Płoski; Ewa Barcz; Piotr Dziunycz; Paweł Kamiński; Grażyna Kostrzewa; Łukasz Milewski; Piotr I Roszkowski; David Senitzer; Jacek Malejczyk; Piotr Kuśnierczyk
Journal:  Immunogenetics       Date:  2015-03-01       Impact factor: 2.846

9.  Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of which is also lacking KIR3DL2.

Authors:  Wanda Niepiekło-Miniewska; Natalia Zuk; Joanna Dubis; Maciej Kurpisz; David Senitzer; Anna Havrylyuk; Ryszard Grendziak; Wojciech Witkiewicz; Valentyna Chopyak; Piotr Kuśnierczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-07-18       Impact factor: 4.291

10.  LILRA6 copy number variation correlates with susceptibility to atopic dermatitis.

Authors:  M R López-Álvarez; W Jiang; D C Jones; J Jayaraman; C Johnson; W O Cookson; M F Moffatt; J Trowsdale; J A Traherne
Journal:  Immunogenetics       Date:  2016-06-22       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.